What is CleanAir Solutions?
CleanAir Solutions operates at the critical intersection of pharmaceutical manufacturing and contamination control. The company specializes in the design and deployment of advanced cleanroom environments that strictly adhere to USP-797 guidelines. Their product portfolio, which includes modular hardwall and softwall cleanrooms, high-efficiency particulate air (HEPA) filtration systems, and specialized furnishings, serves as a cornerstone for medical device manufacturers and pharmaceutical compounding facilities. By prioritizing high-yield environments and rigorous regulatory compliance, CleanAir Solutions has established itself as a vital partner for organizations requiring precise environmental control to maintain product integrity and safety standards.
How much funding has CleanAir Solutions raised?
CleanAir Solutions has raised a total of $58K across 1 funding round:
Debt
$58K
Debt (2021): $58K with participation from PPP
Key Investors in CleanAir Solutions
PPP
Public-Private Partnership
What's next for CleanAir Solutions?
With the recent infusion of capital, CleanAir Solutions is poised to scale its manufacturing capacity and broaden its service footprint. The strategic focus will likely shift toward optimizing supply chain efficiencies and investing in next-generation filtration technology to meet the evolving demands of the life sciences sector. As the company transitions through this significant Series B/C stage, the emphasis remains on maintaining high-quality standards while scaling operations to support a growing client base in the medical device and pharmaceutical industries. Future growth will be driven by the increasing necessity for compliant, modular infrastructure in an era of heightened regulatory scrutiny.
See full CleanAir Solutions company page
